Prokidney (PROK) Interest & Investment Income (2021 - 2026)
Prokidney (PROK) reported Interest & Investment Income of $2.3 million for Q1 2026, down 42.22% year-over-year from $4.0 million in Q1 2025, and down 20.72% quarter-over-quarter from $2.9 million in Q4 2025.
Prokidney (PROK) Interest & Investment Income (2021 - 2026) Analysis & Trends
Prokidney (PROK) has 6 years of Interest & Investment Income data on file, last reported at $2.3 million in Q1 2026.
- Interest & Investment Income for Q1 2026 came in at $2.3 million, down 42.22% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.1 million (down 36.03% YoY), and the FY2025 annual result was $13.8 million, down 30.07% from the prior year.
- Interest & Investment Income retreated to $2.3 million in Q1 2026 per PROK's latest filing, from $2.9 million in the prior quarter.
- Over five years, Interest & Investment Income peaked at $6.0 million in Q2 2023 and troughed at $1.6 million in Q3 2022.
- A 5-year average of $4.3 million and a median of $4.5 million in 2024 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2022 and 2026: Interest & Investment Income soared 52783.23% in 2022, then tumbled 42.22% in 2026.
- A 5-year view of Interest & Investment Income shows it stood at $4.4 million in 2022, then advanced by 19.95% to $5.3 million in 2023, then retreated by 9.24% to $4.8 million in 2024, then plunged by 38.75% to $2.9 million in 2025, then retreated by 20.72% to $2.3 million in 2026.
- Business Quant data shows PROK's Interest & Investment Income at $2.3 million in Q1 2026, $2.9 million in Q4 2025, and $3.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Prokidney | 259.01 Mn | 1.55 Bn | - | 2.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.33 Mn |
| Dec 31, 2025 | 2.94 Mn |
| Sep 30, 2025 | 3.26 Mn |
| Jun 30, 2025 | 3.59 Mn |
| Mar 31, 2025 | 4.03 Mn |
| Dec 31, 2024 | 4.79 Mn |
| Sep 30, 2024 | 5.58 Mn |
| Jun 30, 2024 | 4.54 Mn |
| Mar 31, 2024 | 4.84 Mn |
| Dec 31, 2023 | 5.28 Mn |
| Sep 30, 2023 | 5.54 Mn |
| Jun 30, 2023 | 5.97 Mn |
| Mar 31, 2023 | 5.30 Mn |
| Dec 31, 2022 | 4.40 Mn |
| Sep 30, 2022 | 1.58 Mn |
| Dec 31, 2021 | 8,324.00 |